Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life
Pediatric Pulmonology · 2025
DOI: 10.1002/ppul.27418 ↗At a glance
Journal article in Pediatric Pulmonology, 2025. Written by Elizabeth Clarke and 6 co-authors. Institution: Division of Infection, Immunity & Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. Major MEDLINE topics: Cystic Fibrosis, Activities of Daily Living, Musculoskeletal Diseases, Musculoskeletal Pain. Cited 1 times so far (Crossref); 19 references. The full text is freely available (open access, CC BY 4.0). Funded by: This work was funded by the CF Trust..
Abstract (original language)
Background
Musculoskeletal problems are reported in the literature as a common problem for people with cystic fibrosis, with a range of aetiologies including an inflammatory arthritis. However, accurate data on the presentations and prevalence are lacking. The aim of this cohort study was to describe the scale and impact of musculoskeletal symptoms in CF.
Methods
A collaboratively designed questionnaire was administered to adults attending two large UK CF centres. Data collected evaluated scale and impact of musculoskeletal symptoms.
Results
Results were obtained from 489 patients (response rate 59%). Of these, 49% reported that musculoskeletal symptoms impacted their activities of daily living in the previous year. Back pain was common, occurring in 44% of participants in the preceding week. The knee was the most commonly affected painful peripheral joint, with 26% of participants reporting knee pain within the last week rising to 50% within the last year. Early morning stiffness and joint swelling were markedly less common, suggesting that the majority of musculoskeletal pain in CF is not due to an inflammatory arthritis but is due to other factors.
Conclusion
Musculoskeletal problems are common in CF and frequently affect activities of daily living. Symptoms of inflammatory arthritis occurred in only a small minority of individuals. A focused approach to characterising and clarifying the aetiology of musculoskeletal symptoms is needed to inform the management of these disabling symptoms.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Infection, Immunity & Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
- Rheumatology Department, Royal Alexandra Hospital, NHS Greater Glasgow and Clyde.
- Manchester Adult Cystic Fibrosis Centre, Wythenshawe Hospital, Manchester Foundation NHS Trust, Manchester, UK.
- Rheumatology Department, Wythenshawe Hospital, Manchester Foundation NHS Trust, Manchester, UK.
- NIHR Leeds Biomedical Research Centre and Department of Rheumatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
- Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
Funding
- This work was funded by the CF Trust.
Cite
APA
Clarke, E., Taylor, J., Watson, P., Freeston, J., Jones, A., Peckham, D., & Horsley, A. (2025). Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27418
Vancouver
Clarke E, Taylor J, Watson P, Freeston J, Jones A, Peckham D, et al. Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life. Pediatric Pulmonology. 2025. doi:10.1002/ppul.27418
BibTeX
@article{Clarke2025,
author = {Clarke, Elizabeth and Taylor, Julia and Watson, Pippa and Freeston, Jane and Jones, Andrew and Peckham, Daniel and Horsley, Alex},
title = {Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life},
journal = {Pediatric Pulmonology},
year = {2025},
doi = {10.1002/ppul.27418}
}
EUVIMED